Tinavi Medical TechnologiesLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Tinavi Medical TechnologiesLtd şirketinin toplam hissedar öz sermayesi CN¥1.2B ve toplam borcu CN¥224.3M olup, bu da borç-öz sermaye oranını 18.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥1.5B ve CN¥338.0M dir.

Anahtar bilgiler

18.6%

Borç/özkaynak oranı

CN¥224.32m

Borç

Faiz karşılama oranı	n/a
Nakit	CN¥222.03m
Eşitlik	CN¥1.20b
Toplam yükümlülükler	CN¥338.02m
Toplam varlıklar	CN¥1.54b

Son finansal sağlık güncellemeleri

Is Tinavi Medical TechnologiesLtd (SHSE:688277) A Risky Investment?

Jun 14

Health Check: How Prudently Does Tinavi Medical TechnologiesLtd (SHSE:688277) Use Debt?

Feb 27

Recent updates

What Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) 60% Share Price Gain Is Not Telling You

Oct 09

Is Tinavi Medical TechnologiesLtd (SHSE:688277) A Risky Investment?

Jun 14

More Unpleasant Surprises Could Be In Store For Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Shares After Tumbling 26%

Apr 21

There's Reason For Concern Over Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Massive 25% Price Jump

Mar 06

Health Check: How Prudently Does Tinavi Medical TechnologiesLtd (SHSE:688277) Use Debt?

Feb 27

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 688277 'nin kısa vadeli varlıkları ( CN¥382.9M ) kısa vadeli yükümlülüklerini ( CN¥139.2M ) aşıyor.

Uzun Vadeli Yükümlülükler: 688277 şirketinin kısa vadeli varlıkları ( CN¥382.9M ) uzun vadeli yükümlülüklerini ( CN¥198.8M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 688277 'nin net borç/öz sermaye oranı ( 0.2% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 688277 şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 18.6% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: 688277 şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: 688277 un, serbest nakit akışı her yıl % 31.8 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Tinavi Medical TechnologiesLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Tinavi Medical TechnologiesLtd (SHSE:688277) A Risky Investment?

Health Check: How Prudently Does Tinavi Medical TechnologiesLtd (SHSE:688277) Use Debt?

Recent updates

What Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) 60% Share Price Gain Is Not Telling You

New minor risk - Share price stability

Tinavi Medical Technologies Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Second quarter 2024 earnings released: CN¥0.085 loss per share (vs CN¥0.093 loss in 2Q 2023)

Tinavi Medical Technologies Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

Is Tinavi Medical TechnologiesLtd (SHSE:688277) A Risky Investment?

Tinavi Medical Technologies Co.,Ltd., Annual General Meeting, Jun 27, 2024

Full year 2023 earnings released: CN¥0.35 loss per share (vs CN¥0.26 loss in FY 2022)

More Unpleasant Surprises Could Be In Store For Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Shares After Tumbling 26%

Tinavi Medical Technologies Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024

There's Reason For Concern Over Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Massive 25% Price Jump

Full year 2023 earnings released: CN¥0.36 loss per share (vs CN¥0.26 loss in FY 2022)

Health Check: How Prudently Does Tinavi Medical TechnologiesLtd (SHSE:688277) Use Debt?

Third quarter 2023 earnings released: CN¥0.082 loss per share (vs CN¥0.088 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.093 loss per share (vs CN¥0.039 loss in 2Q 2022)

TINAVI Medical Technologies Co., Ltd. to Report Q2, 2023 Results on Aug 23, 2023

Full year 2022 earnings released: CN¥0.26 loss per share (vs CN¥0.19 loss in FY 2021)

Full year 2022 earnings released: CN¥0.27 loss per share (vs CN¥0.19 loss in FY 2021)

Beijing Huilin Oriental Technology Partnership Enterprise (Limited Partnership) and Wang Binbin entered into an agreement to acquire 12% stake in Beijing Shuimu Dongfang Medical Robotics Technology Innovation Center Co., Ltd. from TINAVI Medical Technologies Co., Ltd. (SHSE:688277).

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.088 loss per share (vs CN¥0.06 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.039 loss per share (vs CN¥0.031 loss in 2Q 2021)

First quarter 2022 earnings released: CN¥0.07 loss per share (vs CN¥0.06 loss in 1Q 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: CN¥0.06 loss per share (vs CN¥0.04 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.031 loss per share (vs CN¥0.049 loss in 2Q 2020)

TINAVI Medical Technologies Co., Ltd. announced that it expects to receive CNY 1.34 billion in funding

First quarter 2021 earnings released: CN¥0.06 loss per share (vs CN¥0.04 loss in 1Q 2020)

Full year 2020 earnings released: CN¥0.14 loss per share (vs CN¥0.08 loss in FY 2019)

New 90-day low: CN¥34.82

New 90-day low: CN¥45.92

New 90-day low: CN¥55.62

TINAVI Medical Technologies Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin